Navigation Links
Cracking the Code: Exclusive Conference to Reveal Secrets of Chinese Pharmaceutical Industry
Date:1/14/2009

NEW YORK, Jan. 14 /PRNewswire/ -- With all the woes of the U.S. economy, many people and businesses are looking to China for better opportunities. After all, China is expected to become the fifth-largest pharmaceutical market in the world by 2010. As the world watches, China is becoming a driving force in the pharmaceutical industry. People who want to be viable in this marketplace must learn to either thrive or die in this dynamic field.

But to survive and thrive overseas, you need the right tools. That's why interest is swelling in an exclusive Pharma China Seminar. The one-day seminar is being offered for three different dates and venues (New Jersey: February 26, 2009; Boston, MA: April 29, 2009; and San Francisco, CA: November 4, 2009).

In just one day, participants will be in the enviable position of learning everything they need to know (and have always wanted to know) about the Chinese Pharmaceutical Industry. This one-of-a-kind seminar is jampacked with the most recent, hard-to-find data, exclusive information, and real-world, on the ground experience you can't find anywhere else.

Momentum is building for this seminar, as participants say they're signing up to help solidify their roles as key players in the pharma industry's growth and expansion.

The following topics will be covered in-depth: regulatory structure, segmentation (hospital, ethical & OTC drugs, vaccines/bio, and others), environment and related issues; intellectual property/patent related issues; pricing and reimbursement/health insurance system; insights into various aspects of Chinese pharma including outsourcing (manufacturing, R&D, licensing/marketing/sales), API/intermediates sector, generic drugs, emerging Chinese global companies, IPOs/M&As/industry consolidation, and emerging pharma/biotech innovation; strategies and resources for market research and business intelligence; future growth drivers and risks, government commitment, opportunities and outlook; and much more!

Today, the spotlight is on the Chinese pharmaceutical industry. The world is looking at China for answers about what's next in pharmaceuticals. The Pharma China Seminar will offer key insight for participants fortunate enough to attend.

The sessions are interactive, and limited to only a small group of executives. That's why everyone is encouraged to register early to reserve their spot.

For more information, the detailed program agenda, or to register, please visit www.pharmachinaseminar.com


'/>"/>
SOURCE Pharma China Seminar
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cracking a tough nut for the semiconductor industry
2. Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
3. Nikon Instruments Introduces Exclusive VAAS Detector Imaging Method for Confocal Microscopy
4. Exclusive Conference on Managing Your Online Brand: Shaping the Noise from the Blogosphere
5. Minimally Invasive Surgery: Olympus Further Enhances Credentials by Entering Into Exclusive Sales and Distribution Partnership With Market and Technology Leader Advanced Surgical Concepts
6. FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract
7. Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products Neurodegenerative Diagnostics
8. VisualSonics and Seno Medical Instruments Sign Exclusive Opto-Accoustic Licensing Agreement for Preclinical Research
9. Cryo-Cell Renews Upromise Industry-Exclusive Agreement
10. GlaxoSmithKline and AFFiRiS Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimers Disease Candidate Vaccines
11. Huifeng Bio-Pharmaceutical (HFGB) Signs Exclusive Management Operating Agreement with Xian Qinba Xintong Medical Ltd.; HFGB to Retain Up to 70% of Qinbas Total Profit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... Cambridge ... a splash at this year’s Bio-IT World Conference and Expo in Boston ... Data Lake® 4.0 solution. The Anzo Smart Data Lake is also a finalist ...
(Date:5/22/2017)... ... 2017 , ... Stratevi, a boutique firm that partners with healthcare companies to ... an office in downtown Boston at 745 Atlantic Ave. , “We are seeing ... evidence on the value they provide, not just to patients, but also payers. Having ...
(Date:5/22/2017)... ... May 22, 2017 , ... Cancer diagnostics and pathology ... B2 at the Association for Pathology Informatics Annual Summit at the ... demonstrating its Cancer Diagnostic Cockpit and Consultation Portal, Inspirata will present research it ...
(Date:5/21/2017)... ... May 20, 2017 , ... CNSDose is a genetically ... error process by finding the right antidepressant faster. CNSDose speeds recovery and ... through a personalized approach to treatment. , A peer-reviewed and published, ...
Breaking Biology Technology:
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
Breaking Biology News(10 mins):